Skip to main content

3 Reasons AMN is Risky and 1 Stock to Buy Instead

AMN Cover Image

Since September 2025, AMN Healthcare Services has been in a holding pattern, floating around $18.89.

Is there a buying opportunity in AMN Healthcare Services, or does it present a risk to your portfolio? Get the full stock story straight from our expert analysts, it’s free.

Why Do We Think AMN Healthcare Services Will Underperform?

We're sitting this one out for now. Here are three reasons you should be careful with AMN and a stock we'd rather own.

1. Long-Term Revenue Growth Disappoints

Reviewing a company’s long-term sales performance reveals insights into its quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years. Over the last five years, AMN Healthcare Services grew its sales at a tepid 2.7% compounded annual growth rate. This fell short of our benchmarks.

AMN Healthcare Services Quarterly Revenue

2. EPS Trending Down

Analyzing the long-term change in earnings per share (EPS) shows whether a company's incremental sales were profitable – for example, revenue could be inflated through excessive spending on advertising and promotions.

Sadly for AMN Healthcare Services, its EPS declined by 16.9% annually over the last five years while its revenue grew by 2.7%. This tells us the company became less profitable on a per-share basis as it expanded.

AMN Healthcare Services Trailing 12-Month EPS (Non-GAAP)

3. New Investments Fail to Bear Fruit as ROIC Declines

We like to invest in businesses with high returns, but the trend in a company’s ROIC can also be an early indicator of future business quality.

We like to invest in businesses with high returns, but the trend in a company’s ROIC is what often surprises the market and moves the stock price. Unfortunately, AMN Healthcare Services’s ROIC has decreased significantly over the last few years. We like what management has done in the past, but its declining returns are perhaps a symptom of fewer profitable growth opportunities.

AMN Healthcare Services Trailing 12-Month Return On Invested Capital

Final Judgment

We see the value of companies making people healthier, but in the case of AMN Healthcare Services, we’re out. That said, the stock currently trades at 9.1× forward P/E (or $18.89 per share). While this valuation is optically cheap, the potential downside is huge given its shaky fundamentals. There are superior stocks to buy right now. We’d recommend looking at a fast-growing restaurant franchise with an A+ ranch dressing sauce.

High-Quality Stocks for All Market Conditions

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  208.06
-3.65 (-1.72%)
AAPL  254.13
+1.51 (0.60%)
AMD  205.09
-15.18 (-6.89%)
BAC  48.38
-0.37 (-0.75%)
GOOG  280.49
-9.10 (-3.14%)
META  546.13
-48.76 (-8.20%)
MSFT  366.24
-4.80 (-1.29%)
NVDA  172.19
-6.50 (-3.63%)
ORCL  143.38
-2.64 (-1.80%)
TSLA  375.39
-10.56 (-2.74%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.